Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemia by Schneider, P, Crump, NT, Arentsen-Peters, STCJM, Smith, AL, Hagelaar, R, Adriaanse, FRS, Bos, RS, de Jong, A, Nierkens, S, Koopmans, B, Milne, TA, Pieters, R, Stam, RW